Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
INmune Bio, Inc. (INMB) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-24.46M |
|
-- |
|
-- |
|
$24.57M |
|
$-24.57M |
|
$0.11M |
|
$-24.46M |
|
$-24.46M |
|
$-24.46M |
|
$-24.46M |
|
$-24.46M |
|
$-24.46M |
|
$-24.57M |
|
$-24.57M |
|
23.30M |
|
23.30M |
|
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$36.03M |
|
$0.71M |
|
$1.65M |
|
$37.68M |
|
$8.59M |
|
-- |
|
$0.23M |
|
$8.82M |
|
$28.87M |
|
$28.87M |
|
$28.87M |
|
26.59M |
|
| Cash Flow Statement Financials | |
$-14.20M |
|
$-0.71M |
|
$27.55M |
|
$20.92M |
|
$33.37M |
|
$12.45M |
|
$3.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.20 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-84.73% |
|
-84.73% |
|
-64.90% |
|
-84.73% |
|
$1.09 |
|
$-0.61 |
|
$-0.61 |
|